Kate Baron, MD (@KateBaronMD1) header
Kate Baron, MD (@KateBaronMD1) profile picture

PGY-4 Surgical Resident @mfldclinic | Former HIPEC Researcher @MDMercyMedia | Fortunate wife to @ANikiforchin | Future #SurgOnc 🧬

Marshfield, WI
Joined March 2021
Photo by Kate Baron, MD (@KateBaronMD1)Photo by Kate Baron, MD (@KateBaronMD1)Photo by Kate Baron, MD (@KateBaronMD1)Photo by Kate Baron, MD (@KateBaronMD1)Photo by Kate Baron, MD (@KateBaronMD1)Photo by Kate Baron, MD (@KateBaronMD1)
New in Cancer: Joint series w/ @AnnSurgOncol on consensus guidelines for managing peritoneal surface malignancies from a multidisciplinary expert panel. 🎥 Watch an intro from @kturaga and explore the full collection: acsjournals.onlinelibrary.wi… @OncoAlert @YaleMedicine
1
17
1
32
7,398
🎙️ CancerSpeak Mini Ep. 3: @ElizLGodfreyMD talks with Drs. White & Raoof about updated guidance on appendiceal tumors with peritoneal involvement—part of the PSM guideline series. 🎧 Listen: cancerspeak.podbean.com/e/ca… 📖 Read: acsjournals.onlinelibrary.wi… @oncoalert @YaleCancer
6
7
915
🔖 Also available in @AnnSurgOncol - doi.org/10.1245/s10434-025-1… Countless thanks and huge congrats to the incredible #PSM Consortium Team 👩‍⚕️👨‍🔬👏 @kturaga @sbutensky @Varun_VBSurg @GomezJorgeMD @mtalhawaheed @ElizLGodfreyMD @KateBaronMD1 @FelipeLopezMD @Yale @YaleMed @YaleSurgery
📑 Immensely grateful to be part of @YaleMed #PSM Consortium team and work on this new guideline for #GastricCancer + #peritoneal mets - just out in @JournalCancer 📢 Huge thanks to @kturaga @sbutensky @Varun_VBSurg for the invitation 🤝 🔗 doi.org/10.1002/cncr.35870 @YaleSurgery
17
1
31
3,936
📑 Immensely grateful to be part of @YaleMed #PSM Consortium team and work on this new guideline for #GastricCancer + #peritoneal mets - just out in @JournalCancer 📢 Huge thanks to @kturaga @sbutensky @Varun_VBSurg for the invitation 🤝 🔗 doi.org/10.1002/cncr.35870 @YaleSurgery
4
3
21
6,697
🎥 Sometimes, complete cytoreduction for #LAMN calls for bold moves - like this one, vibrantly featured by @ResearchSurgOnc team in @AnnSurgOncol 👩‍⚕️🧑‍⚕️ 🔪🔥 Your weekend CRS-#HIPEC must-watch: doi.org/10.1245/s10434-025-1… @VadimGushchin6 @MaryCaitKing @IugaiSergeiMD @ArmandoSardiMD
1
9
1
23
1,180
📊 What can an elevated pre-surgery #CRP tell about mucinous #AppendixCancer prognosis? Find out in the latest @ejsotweets publication by @ResearchSurgOnc team 👩‍🔬👨‍⚕️ Kudos to my amazing co-authors! 👏 🔖Full text: authors.elsevier.com/c/1kgeu… @VadimGushchin6 @ArmandoSardiMD
1
8
1
11
903
I was happy to present our study on the role of prior non-definitive surgery in #CRSHIPEC outcomes for #AppendixCancer patients. I hope this research contributes to raising awareness about peritoneal malignancies within the surgical community. Grateful to Dr. @RussellBrownMD for his thoughtful review and insightful questions, and to @SESC_AmSurg for the opportunity to share our work. Truly honored that our project received a Gold Medal Nomination—a meaningful recognition for the entire @MDMercyMedia team! Looking forward to more surgical insights! #SESC25 #SurgicalOncology
3
4
1
14
750
Excited to present our @mfldclinic work on the feasibility of robotic CRS-#HIPEC 🔥 for low tumor burden #PSM and reconnect with friends and colleagues at #ACT2025 👩‍⚕🤝👨‍⚕ @SocSurgOnc
2
4
12
509
Happy #InternationalDayofWomenandGirlsinScience! Today, we celebrate the incredible women shaping the future of surgical oncology through research, innovation, and leadership. SSO is proud to support and uplift women in science! #SSOCommunity
3
3
20
1,209
Risk factors of a positive resection margin in locoregional #AppendixCancer and its impact on survival: The national cancer database analysis @KateBaronMD1 @ANikiforchin ow.ly/fm8J50T4QzO @FlavioRochaMD @HalletJulie @SKMaithel @JulietOkoroh @TheNotoriousHPB
3
4
528
With proliferation of large databases research, it's inevitable that there's some misalignment of research ❓& dataset capabilities. Since I had to prep slides for 🗣️, thought I could share them if it's helpful for anyone conducting research or reviewing papers. A primer🧵:
14
98
14
406
173,227
👏 Kudos to phenomenal @KateBaronMD1 and incredible @mfldclinic #SurgOnc team for this outstanding @SurgOncInsight paper on risk factors and the impact of #ResectionMargin in stage I-III #AppendixCancer 🎗️ Perfect read for the weekend 📚 📑Open access: doi.org/10.1016/j.soi.2024.1…
2
1
12
673
In Press: Discover how a positive #ResectionMargin worsens overall survival in locoregional #AppendixCancer in our recent #SurgicalOncologyInsight publication @KateBaronMD1 @ANikiforchin @mfldclinic ow.ly/3wrC50StgeL @FlavioRochaMD @DrMikeCavnar @SKMaithel @JulietOkoroh
5
1
8
960
🎥 Thrilled to share my first-ever teaching surgical video in @AnnSurgOncol featuring a complex #robotic resection of paraaortic #paraganglioma and its further management 🚀 Kudos to my incredible co-authors @KateBaronMD1, Dr. Wernberg, and Dr. Sharma 👏 link.springer.com/article/10…
2
4
1
13
878
One of the best parts of #SSO2024 was getting to connect with old and new friends and awesome colleagues 🧡 @KateBaronMD1 I had missed you! – at Boston, MA
1
2
7
297
A lot of inspiration from bright and outstanding presentations at #SSO2024 in Atlanta. Congratulations @LFallaZuniga on an excellent talk. These days I was so happy to met new people as well as old friends. – at Atlanta, GA
4
8
403
Heading to #SSO2024 conference! Excited to learn from surgical oncology experts, see old friends, and present new data on #AppendixCancer and #PSM. Can't wait! @SocSurgOnc – at Atlanta, GA
1
3
23
1,200
We can't wait to see you in Atlanta for #SSO2024! Safe travels and see you soon!
9
2
37
4,124
Incredible scientific debate on the hot and controversial topic - preoperative chemo in appendix cancer patients undergoing #HIPEC. Thank you Dr.@ArmandoSardiMD and Dr. Sameer Patel for the pleasure to watch. #ACT2024 🇵🇷
2
10
281